Plasma Lyso-PE 22:6 and Lyso-PE 20:4 are associated with development of mild to moderate depression revealed by metabolomics: a pilot study.
Journal:
BMC psychiatry
Published Date:
Jul 1, 2025
Abstract
BACKGROUND: Mild to moderate depression (MMD), as an early stage of depression, has a high incidence and may progress to severe depression, even leading to suicide. The lack of effective screening and treatment is due to the unknown metabolic changes and processes in patients with MMD. Here, we performed metabolite profiling to investigate the key metabolites associated with MMD in plasma.